What’s in the Pipeline for Pharma?
Add bookmark
Pharma power play hinges mostly on the initial R&D race to market dominance. Research innovation and investment has enticing potential. The Pharmaceutical industry pipeline was noted to have seen a 5% year on year increase in the first quarter of 2016 1. Just under 70% of that pipeline is covered by the therapy areas of oncology, infectious diseases and central nervous system disorders. The same report noted that the price to bring a single novel drug to market rested at around $...
